BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 22, 2008
View Archived Issues
Ispinesib appears to be well tolerated in phase I/II breast cancer study
Read More
Phase I evaluation of everolimus in hepatocellular carcinoma continues
Read More
VEGF-Trap results disappointing in phase II metastatic breast cancer study
Read More
Dose-related efficacy seen with AVE-0010 in type 2 diabetes
Read More
Panobinostat's efficacy in solid and hematologic tumors opens a new line of research in SCLC
Read More
Health Canada approves Stem Cell's phase IIa study of hCG and EPO in TBI
Read More
Upstream and Makerere University initiate animal efficacy for trypanosomiasis treatment
Read More
Takeda to initiate Japanese phase III trial of cetilistat and pay milestone payment to Alizyme
Read More
Bayer HealthCare acquires Direvo for EUR 210 million cash
Read More
Javelin completes enrollment in phase III clinical study of Dyloject in postoperative pain
Read More
Generex reaches enrollment milestone in phase III clinical trial of Oral-lyn
Read More
Y's Therapeutics completes phase IIa clinical trial of YSPSL for IRI in kidney transplants
Read More
Pluristem reports final results from preclinical animal efficacy studies of PLX-PAD
Read More
Ambrilia develops 1-month formulation of goserelin for hormone-sensitive prostate cancer
Read More
FDA issues complete response letter rejecting approval of Gilead's NDA for aztreonam lysine
Read More
Sucampo presents results from Japanese phase IIb Amitiza trial
Read More
Erbitux launched in Japan for the treatment of colorectal cancer
Read More
Recent Theravance and Argenta patents describe new treatments for respiratory disorders
Read More
FDA grants orphan drug status for patented stem cells in bone marrow transplant
Read More
Cyclacel revises operating plan to concentrate resources on advancement of sapacitabine
Read More
Sinovac initiates clinical trials in Ukraine of Healive inactivated hepatitis A vaccine
Read More
Cleveland BioLabs awarded USD 13.3 million contract for Protectan CBLB-502
Read More
Sciele reports results from two phase III studies of glycopyrrolate for pediatric patients
Read More
Three Rivers obtains commercial rights in all markets except Japan to Amgen's Infergen
Read More
Novel therapeutic agents for cardiovascular disorders covered in recent patents
Read More
Eisai describes new treatment options for multiple sclerosis
Read More